PRF1 and melanoma: In anti-PD-1 research in specific, Bifidobacterium has been noted to assist to potentiate anti-PD-1 monoclonal antibodies efficacy in melanoma mouse models, and its metabolite inhibited PD-1 expression activating natural killer immune cells helping to destroy tumor cells by perforin and interferon-gamma mediation [28,34].